Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 26, 2023
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
[ Thu, Jan 26th 2023
] - WOPRAI
Corinne Jenkins Maintained (SWTX) at Strong Buy with Increased Target to $45 on, Jan 26th, 2023
Corinne Jenkins of Goldman Sachs, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Increased Target from $40 to $45 on, Jan 26th, 2023.
Corinne has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Corinne's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Corinne
- Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $45 on, Thursday, December 1st, 2022
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $99 on, Friday, November 4th, 2022
